(Q36956364)

17 August 2017

1 reference

title

Treatment of DVT: how long is enough and how do you predict recurrence (English)

1 reference

17 August 2017

Giancarlo Agnelli

1

1 reference

17 August 2017

Cecilia Becattini

series ordinal

2

1 reference

17 August 2017

language of work or name

1 reference

1 October 2007

1 reference

Journal of Thrombosis and Thrombolysis

17 August 2017

published in

1 reference

17 August 2017

volume

25

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

37-44

1 reference

https://scigraph.springernature.com/pub.10.1007/s11239-007-0103-z

17 August 2017

exact match

0 references

cites work

Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-007-0103-Z

Extended oral anticoagulant therapy after a first episode of pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-007-0103-Z

Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-007-0103-Z

Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-007-0103-Z

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

21 January 2018

1 reference

12 December 2020

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

1 reference

12 December 2020

Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial

1 reference

12 December 2020

Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism

1 reference

12 December 2020

Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study

1 reference

12 December 2020

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism

1 reference

12 December 2020

The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly.

1 reference

12 December 2020

High risk of recurrent venous thromboembolism in men

1 reference

12 December 2020

Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review

1 reference

12 December 2020

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

1 reference

12 December 2020

Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped

1 reference

12 December 2020

The risk of recurrent venous thromboembolism in men and women

1 reference

12 December 2020

Thrombophilia, clinical factors, and recurrent venous thrombotic events

1 reference

12 December 2020

Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis.

1 reference

12 December 2020

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study

1 reference

12 December 2020

The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation

1 reference

12 December 2020

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism

1 reference

12 December 2020

The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis

1 reference

12 December 2020

Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism

1 reference

12 December 2020

Deep vein thrombosis and pulmonary embolism in the general population. 'The Study of Men Born in 1913'

1 reference

12 December 2020

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

12 December 2020

Risk of fatal pulmonary embolism in patients with treated venous thromboembolism.

1 reference

12 December 2020

Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society

1 reference

12 December 2020

The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden)

1 reference

12 December 2020

D-dimer testing to determine the duration of anticoagulation therapy

1 reference

12 December 2020

Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis

1 reference

12 December 2020

Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis

1 reference

12 December 2020

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

12 December 2020

Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.

1 reference

12 December 2020

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

1 reference

12 December 2020

Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology

1 reference

12 December 2020

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

1 reference

12 December 2020

Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis

1 reference

12 December 2020

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

1 reference

12 December 2020

Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators

1 reference

12 December 2020

A prospective study on cardiovascular events after acute pulmonary embolism

1 reference

12 December 2020

Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis

1 reference

12 December 2020

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

1 reference

12 December 2020

Duration of anticoagulation following venous thromboembolism: a meta-analysis

1 reference

12 December 2020

Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group.

1 reference

12 December 2020

10.1007/S11239-007-0103-Z

Identifiers

DOI

1 reference

17 August 2017

1 reference